Endologix Inc (ELGXQ)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

2 MUSICK IRVINE, CA 92618

Endologix Inc. develops, manufactures, sells and markets minimally invasive therapies for treatment of cardiovascular disease. Its products, the Powerlink System and PowerWeb System, are catheter-based alternative treatments for abdominal aortic aneury® a weakening of the wall of the aorta.

Data as of 2019-12-02 11:39:41 -0500
Market Cap46.649 Million Shares Outstanding17.942 Million Avg 30-day Volume
P/E Ratio Dividend Yield EPS-6.67
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA 52-week High/Low9.3 / 2.28 Next Earnings Date Price to Cash FLow (P/CF)
Data provided by IEX Cloud
View SEC Filings from ELGXQ instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 1 -100.0% 0 (0.0%) 1 (0.06%) -100.0%
Funds Holding: 2 6 -66.67% 1 (0.06%) 3 (0.19%) -66.67%
13F shares: 3.903 Thousand 299.243 Thousand -98.7% 3.408 Thousand 148.641 Thousand -97.71%
% Ownership 1.4486 0.7196
New Positions: 1 2 -50.0%
Increased Positions 1
Closed Positions 5 43 -88.37% 2 15 -86.67%
Reduced Positions 1 1
Total Calls 0 5 -100.0%
Total Puts
PUT/CALL Ratio 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding ELGXQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding ELGXQ BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

LEMAITRE DAN

  • Director
0 2020-09-04 2

WILDER THOMAS

  • Director
0 2020-08-12 1

WALLER GREGORY D

  • Director
710 2020-08-12 1

ONOPCHENKO JOHN CEO AND DIRECTOR

  • Officer
  • Director
165,698 2020-08-12 2

THOMPSON MATTHEW CHIEF MEDICAL OFFICER

  • Officer
52,878 2020-08-12 2

BRADY TIMOTHY NICHOLAS CONTROLLER AND CORP SECRETARY

  • Officer
891 2020-08-12 3

PINTO CYNTHIA BUCH INTERIM CFO

  • Officer
6,304 2020-08-12 5

FECHO JEFF CHIEF QUALITY OFFICER

  • Officer
23,732 2020-08-05 2

MOTT RICHARD W

  • Director
0 2020-06-19 1

MAHBOOB VASEEM CHIEF FINANCIAL OFFICER

  • Officer
111,716 2020-03-24 0

KIERNAN JANE E

  • Director
103,847 2020-03-18 0

ZEHREN JOHN CHIEF COMMERCIAL OFFICER

  • Officer
40,138 2020-01-07 0

HAYDEN JEREMY B. GENERAL COUNSEL

  • Officer
32,040 2019-10-03 0

ZENTY III THOMAS F

  • Director
35,547 2019-08-05 0

NORWALK LESLIE V

  • Director
29,932 2019-08-05 0

NEELS GUIDO J

  • Director
43,200 2019-04-03 0

CAMBER CAPITAL MANAGEMENT LP

9,300,000 2018-10-29 0

CHAVEZ CHRISTOPHER G.

  • Director
378,346 2018-05-29 0

MCDERMOTT JOHN D

  • Director
879,423 2018-05-28 0

NAGEL LAURA VP, QUALITY

  • Officer
48,860 2018-03-13 0

MITCHELL ROBERT D PRESIDENT

  • Officer
316,886 2017-06-19 0

O'QUINN SHARI L VP, CLINICAL & REGULATORY

  • Officer
94,356 2017-05-31 0

LIMA JOSE A. VP-QUALITY

  • Officer
37,884 2016-08-19 0

CHOBOTOV MICHAEL V. CHIEF TECHNOLOGY OFFICER

  • Officer
189,269 2016-08-05 0

DEJOHN JOSEPH A. GENERAL MANAGER, ASIA & PAC

  • Officer
No longer subject to file 2016-07-08 0

JENNINGS DAVID M. VP-HUMAN RESOURCES

  • Officer
50,281 2016-06-01 0

MACHEK JAMES EDWARD VP-RESEARCH & DEVELOPMENT

  • Officer
38,286 2016-06-01 0

DEPALMA AMANDA L. VP, GLOBAL MARKETING

  • Officer
43,772 2016-06-01 0

FERRACCI CECILE GENERAL MANAGER, EUROPE

  • Officer
40,706 2016-02-04 0

LOVE CHARLES STEELE VP-CLINICAL AFFAIRS

  • Officer
45,037 2016-01-26 0

ABRAHAM TODD VP OF OPERATIONS

  • Officer
86,821 2015-11-13 0

THUNEN SHELLEY B

  • NAMED EXECUTIVE OFFICER
No longer subject to file 2015-10-19 0

FAULS JANET MARY VP REGULATORY AFFAIRS

  • Officer
82,492 2015-05-28 0

LYONS RUTH ANNE VP GLOBAL MARKETING

  • Officer
27,168 2014-03-14 0

SCHRECK STEFAN VICE PRESIDENT

  • Officer
No longer subject to file 2013-10-11 0

GREENSTEIN LEONARD M. VP FINANCE & CORP CONTROLLER

  • Officer
No longer subject to file 2013-10-03 0

SORSHER GARY I. VICE PRESIDENT - QUALITY

  • Officer
No longer subject to file 2013-09-27 0

TYLER MARTIN VP, INTERNATIONAL

  • Officer
14,472 2013-03-15 0

DE GREEF RODERICK

  • Director
7,102 2013-03-08 0

KRIST ROBERT JOHN CHIEF FINANCIAL OFFICER

  • Officer
142,236 2012-12-28 0

ESSEX WOODLANDS HEALTH VENTURES FUND VII LP

  • 10% Owner
1,165,428 2012-11-01 0

BROWN FRANKLIN D

  • Director
64,700 2011-11-03 0

ELLIOTT ASSOCIATES, L.P.

  • 10% Owner
No longer subject to file 2010-12-14 0

ELLIOTT INTERNATIONAL, L.P.

  • 10% Owner
No longer subject to file 2010-12-14 0

ODONNELL JEFFREY F

  • Director
0 2010-05-20 0

MCCORMICK PAUL

  • Director
333 2010-04-30 0

HAWKINS DANIEL VICE PRES - GLOBAL MARKETING

  • Officer
0 2009-04-10 0

DIETHRICH EDWARD

  • Director
0 2008-05-22 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments